Amalgamated Bank Chinook Therapeutics, Inc. Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$18.66 - $38.58 $19,369 - $40,046	1,038 Added 19.69%	6,310 $242,000
Q1 2023 May 02, 2023	SELL	$21.53 - $26.8 $28,591 - $35,590	-1,328 Reduced 20.12%	5,272 $122,000
Q4 2022 Feb 10, 2023	BUY	$18.63 - $27.35 $2,943 - $4,321	158 Added 2.45%	6,600 $173,000
Q3 2022 Nov 09, 2022	BUY	$17.51 - $23.37 $15,618 - $20,846	892 Added 16.07%	6,442 $127,000
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $10,638 - $15,886	845 Added 17.96%	5,550 $97,000
Q1 2022 Jun 30, 2022	BUY	$12.02 - $16.69 $56,554 - $78,526	4,705 New	4,705 $77,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.